870-871 / 1578
Moderately central tumors
Ultracentral tumors
Use of SABR is feasible
ASTRO guidelines [Videtic
GMM, Prac Rad Onc 2017]
Higher toxicity with high-
dose radiation
[MSKCC,
Tekatli H, JTO 2016; HILUS-
Lindberg K, WCLC 2016]
Moderately central vs ‘ultracentral’ tumors